Drugs / AKM Lab-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07331974 | Jul 2026 → Jan 2027 expected | obesity disorder | Moon (Guangzhou) Biotechnology Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AKM Lab-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07331974 ↗ |
| Route | Oral | “A specific dose of AKM Lab-01 will be administered orally once daily for a period of 3 months.” NCT07331974 ↗ |